Axcelon Biopolymers and Rodocanachi Capital Sign LOI

Rodocanachi Capital Inc. ("Rodocanachi") (TSX VENTURE:ROD.P), a capital pool company (as defined in Policy 2.4 (the "CPC Policy") of the TSX Venture Exchange (the "Exchange")), is pleased to announce that it has entered into a letter of intent dated August 4, 2010 (the "Agreement") with Axcelon Biopolymers Corp. ("Axcelon"), to pursue a possible business combination transaction (the "Proposed Transaction") with Axcelon and its shareholders.

If the Proposed Transaction is completed as currently envisioned (the "Closing"), Rodocanachi would acquire all of the issued and outstanding common shares in the capital of Axcelon (the "Axcelon Shares") in exchange for the issuance of an aggregate of 50,000,000 of common shares in the capital of Rodocanachi (the "Rodocanachi Shares") at a price per Rodocanachi Share equal to $0.10 (on the basis of an exchange ratio of 6.48 Rodocanachi Shares for each one Axcelon Share). Immediately after the Closing and as a result of the Share Exchange, (i) Axcelon would be a direct, wholly-owned subsidiary of the Resulting Issuer (the "Resulting Issuer" being Rodocanachi immediately after the Closing), and (ii) the Axcelon Shareholders will collectively exercise control over the Resulting Issuer. The parties, along with their advisors, will consider and confirm that a share exchange is the most effective means to structure and consummate the Proposed Transaction.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.